Home › Trial NCT00930891
Bevacizumab in Extensive Small Cell Lung Cancer
- Trial IDNCT00930891
- StatusCompleted
- PhasePhase 2/3
- Study typeInterventional
- SponsorIntergroupe Francophone de Cancerologie Thoracique
- Enrollment143
- Start date2009-09
- ConditionsSmall Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.